Bioequivalence and Bioavailability Forum

Cholestyramine and colesevelam in Vitro binding studies jansari 2024-09-02 17:25

Acute and Sub-acute toxicity studies for FDA ANDAs Achievwin 2024-08-05 18:50
- Acute and Sub-acute toxicity studies for FDA ANDAs NK 2024-08-06 04:06
  - Acute and Sub-acute toxicity studies for FDA ANDAs Achievwin 2024-08-27 02:42

EU Reference Medicinal Product – Flexible or Absolute? PE 2024-08-20 10:39
- EEA Reference Medicinal Product: Mandatory Helmut 2024-08-20 12:17

Predose concentration more than 5 % of Cmax NK 2024-08-05 06:07
- FDC or isomers: C0 > 5 % of Cmax Helmut 2024-08-05 08:36
  - FDC or isomers: C0 > 5 % of Cmax Achievwin 2024-08-05 19:08
    - Carryover. A Never Ending Story. Helmut 2024-08-05 22:39
  - Inducers/inhibitors Ohlbe 2024-08-08 18:09
    - Inducers/inhibitors Helmut 2024-08-09 08:26
- Predose concentration more than 5 % of Cmax qualityassurance 2024-08-05 12:48

FDC with ascorbic acid qualityassurance 2024-07-23 08:08
- FDC with ascorbic acid Ohlbe 2024-07-23 09:55
  - FDC with ascorbic acid qualityassurance 2024-07-23 10:13
    - Placebo? Helmut 2024-07-23 12:39
      - Placebo? mittyri 2024-07-23 14:54
        
        🇦🇹 AGES Helmut 2024-07-24 11:16
      - Placebo? qualityassurance 2024-07-24 11:37
        
        Sorry – wrong addressee Helmut 2024-07-24 13:31
        
        lucky mittyri 2024-07-24 16:01

Brazil, Mexico: Proc GLM or Proc Mixed? jag009 2024-07-17 20:29
- Brazil, Mexico: Proc GLM? Helmut 2024-07-18 09:01
  - Mexico: new guideline Ohlbe 2024-07-18 09:40
    - Mexico: ABEL Helmut 2024-07-18 10:42
      - Mexico: ABEL NK 2024-07-19 07:30
        
        Mexico: ABEL Helmut 2024-07-19 09:26
        
        Mexico: ABEL jag009 2024-07-23 19:43

full replicate study for drug not highly variable - EMA perspective Ankit Parikh 2024-07-11 04:40
- EMA: Full replicate study Helmut 2024-07-15 09:13

Need some clarity on eCTD module 5 jag009 2024-07-12 16:04

FDC: BA/BE study enough? qualityassurance 2024-07-03 05:21
- FDC: DDI study generally sufficient Helmut 2024-07-03 08:05

back conversion test Thair Saleh 2024-07-01 09:42

average bioequivalence Mahmoud 2024-06-24 11:29
- Partial replicate design: ABE Helmut 2024-06-27 08:00

Biocomparability study suchit_bhavsar 2024-06-12 09:01
- Biocomparability study Helmut 2024-06-12 09:48

Orlistat PD Endpoint BE study NK 2024-04-30 04:33

ICH M10 - Method validation - Anchoring points-reg ryraman2661 2024-03-20 04:51
- ICH M10 - Method validation - Anchoring points-reg Ohlbe 2024-03-20 10:50
- LBAs: Anchor points and model fitting Helmut 2024-03-21 17:42
  - LBAs: Anchor points and model fitting ryraman2661 2024-03-25 12:28

Tmax guideline Laura Carreiras 2024-02-16 15:05
- The minefield… Helmut 2024-02-16 15:59

Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
116 visitors (0 registered, 116 guests [including 23 identified bots]).
Forum time: 21:03 CEST (Europe/Vienna)

I have never in my life learned anything
from any man who agreed with me. Dudley Field Malone

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz